Basel, Switzerland

Lene Frederiksen

This inventor holds 1 USPTO granted patent. Top assignee: Ciba-Geigy Corporation. Active years: 1997.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 61(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lene Frederiksen: Innovator in Liposome Technology

Introduction

Lene Frederiksen is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceutical technology, particularly in the preparation of liposome dispersions. Her innovative approach has the potential to enhance the delivery of water-soluble substances in medical applications.

Latest Patents

Lene Frederiksen holds a patent for a process for the preparation of a liposome dispersion under elevated conditions. This invention relates to a novel and advantageous method for creating liposomes that can encapsulate water-soluble or hydrophilic substances. The process offers a surprising advantage over known methods by increasing the proportion of substances actually included in the liposomes. Additionally, it provides sterile working conditions, which is crucial for pharmaceutical applications.

Career Highlights

Frederiksen is associated with Ciba-Geigy Corporation, where she has been instrumental in advancing liposome technology. Her work has garnered attention for its innovative approach and practical applications in the pharmaceutical industry.

Collaborations

Throughout her career, Lene has collaborated with notable colleagues, including Klaus Anton and Peter Van Hoogevest. These partnerships have contributed to her success and the development of her patented processes.

Conclusion

Lene Frederiksen's contributions to liposome technology represent a significant advancement in pharmaceutical science. Her innovative processes have the potential to improve drug delivery systems, making her a key figure in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…